Búsqueda | Portal de Búsqueda de la BVS España

1.

A proof of concept reinforcement learning based tool for non parametric population pharmacokinetics workflow optimization.

Otalvaro, J D; Yamada, W M; Hernandez, A M; Zuluaga, A F; Chen, R; Neely, M N.

J Pharmacokinet Pharmacodyn; 50(1): 33-43, 2023 02.

Artículo en Inglés | MEDLINE | ID: mdl-36478350

2.

Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?

Drusano, G L; Duncanson, Brandon; Scanga, C A; Kim, S; Schmidt, S; Neely, M N; Yamada, W M; Vicchiarelli, Michael; Peloquin, C A; Louie, Arnold.

Antimicrob Agents Chemother; 64(12)2020 11 17.

Artículo en Inglés | MEDLINE | ID: mdl-32958720

3.

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model.

Drusano, G L; Neely, M N; Yamada, W M; Duncanson, Brandon; Brown, David; Maynard, Michael; Vicchiarelli, Michael; Louie, Arnold.

Antimicrob Agents Chemother; 62(12)2018 12.

Artículo en Inglés | MEDLINE | ID: mdl-30249700

4.

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.

Ramos-Martín, V; Neely, M N; Padmore, K; Peak, M; Beresford, M W; Turner, M A; Paulus, S; López-Herce, J; Hope, W W.

Antimicrob Agents Chemother; 61(10)2017 10.

Artículo en Inglés | MEDLINE | ID: mdl-28760897

5.

Pharmacodynamics of teicoplanin against MRSA.

Ramos-Martín, V; Johnson, A; McEntee, L; Farrington, N; Padmore, K; Cojutti, P; Pea, F; Neely, M N; Hope, W W.

J Antimicrob Chemother; 72(12): 3382-3389, 2017 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-28962026

6.

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.

Ramos-Martín, V; Neely, M N; McGowan, P; Siner, S; Padmore, K; Peak, M; Beresford, M W; Turner, M A; Paulus, S; Hope, W W.

J Antimicrob Chemother; 71(11): 3168-3178, 2016 11.

Artículo en Inglés | MEDLINE | ID: mdl-27543654

7.

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Felton, T W; Roberts, J A; Lodise, T P; Van Guilder, M; Boselli, E; Neely, M N; Hope, W W.

Antimicrob Agents Chemother; 58(7): 4094-102, 2014 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-24798288

8.

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

Felton, T W; Goodwin, J; O'Connor, L; Sharp, A; Gregson, L; Livermore, J; Howard, S J; Neely, M N; Hope, W W.

Antimicrob Agents Chemother; 57(12): 5811-9, 2013 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-24002098

9.

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

Märtson, A-G; Sturkenboom, M G G; Stojanova, J; Cattaneo, D; Hope, W; Marriott, D; Patanwala, A E; Peloquin, C A; Wicha, S G; van der Werf, T S; Tängdén, T; Roberts, J A; Neely, M N; Alffenaar, J-W C.

Clin Microbiol Infect; 26(8): 1008-1016, 2020 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-32205294

10.

Arrangement and functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin.

Neely, M N; Friedman, D I.

Gene; 223(1-2): 105-13, 1998 Nov 26.

Artículo en Inglés | MEDLINE | ID: mdl-9858702

11.

Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release.

Neely, M N; Friedman, D I.

Mol Microbiol; 28(6): 1255-67, 1998 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-9680214

12.

Kinetics of expression of the Escherichia coli cad operon as a function of pH and lysine.

Neely, M N; Olson, E R.

J Bacteriol; 178(18): 5522-8, 1996 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-8808945

13.

N-mediated transcription antitermination in lambdoid phage H-19B is characterized by alternative NUT RNA structures and a reduced requirement for host factors.

Neely, M N; Friedman, D I.

Mol Microbiol; 38(5): 1074-85, 2000 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-11123680

14.

The exciting future of antifungal therapy.

Neely, M N; Ghannoum, M A.

Eur J Clin Microbiol Infect Dis; 19(12): 897-914, 2000 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-11205627

15.

Roles of LysP and CadC in mediating the lysine requirement for acid induction of the Escherichia coli cad operon.

Neely, M N; Dell, C L; Olson, E R.

J Bacteriol; 176(11): 3278-85, 1994 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-8195083

16.

Altered pH and lysine signalling mutants of cadC, a gene encoding a membrane-bound transcriptional activator of the Escherichia coli cadBA operon.

Dell, C L; Neely, M N; Olson, E R.

Mol Microbiol; 14(1): 7-16, 1994 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-7830562

17.

A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains.

Champion, G A; Neely, M N; Brennan, M A; DiRita, V J.

Mol Microbiol; 23(2): 323-31, 1997 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-9044266

18.

Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain.

Wagner, P L; Neely, M N; Zhang, X; Acheson, D W; Waldor, M K; Friedman, D I.

J Bacteriol; 183(6): 2081-5, 2001 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-11222608

19.

Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time.

Neely, M N; Schreiber, J R.

Pediatrics; 107(2): 404-5, 2001 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-11158475

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

A proof of concept reinforcement learning based tool for non parametric population pharmacokinetics workflow optimization.

Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model.

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.

Pharmacodynamics of teicoplanin against MRSA.

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

Arrangement and functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin.

Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release.

Kinetics of expression of the Escherichia coli cad operon as a function of pH and lysine.

N-mediated transcription antitermination in lambdoid phage H-19B is characterized by alternative NUT RNA structures and a reduced requirement for host factors.

The exciting future of antifungal therapy.

Roles of LysP and CadC in mediating the lysine requirement for acid induction of the Escherichia coli cad operon.

Altered pH and lysine signalling mutants of cadC, a gene encoding a membrane-bound transcriptional activator of the Escherichia coli cadBA operon.

A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains.

Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain.

Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time.